Tapentadol modified release

Amber-G

Brand Name(s):Palexia SR

Indication:Severe chronic pain

Rationale:

Considered:Jul-11

Review Date:Jan-24

Comments:
Drug Safety Update
Tapentadol (Palexia): risk of seizures and reports of serotonin syndrome when co-administered with other medicines
Jan 2019
……………….
For palliative care and chronic pain patients only as 3rd line use as per Formulary guidance.
July 2013